ArticleEMBO molecular medicine2021
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models.
Ilaria Marrocco et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it